Member Exclusive

Minimizing bias in target selection by exploiting multidisciplinary Big Data and the protein interactome

Available to view on demand. You'll learn how to use canSAR to enhance selection of new cancer drug targets - currently a major focus area to reduce attrition in the clinic.

Go to the profile of RxNet
Nov 30, 2016

Please sign in or register for FREE

No comments yet.